Heparin II domain of fibronectin mediates contractility through an α4β1 co-signaling pathway

详细信息    查看全文

• 作者：Marie K. Schwinn ; Jose M. Gonzalez Jr. ; B'Ann T. Gabelt ; Nader Sheibani ; Paul L. Kaufman ; Donna M. Peters
• 关键词：Actin cytoskeleton ; Contractility ; Integrins ; Heparin II domain ; Trabecular meshwork
• 刊名：Experimental Cell Research
• 出版年：2010
• 出版时间：15 May 2010
• 年：2010
• 卷：316
• 期：9
• 页码：1500-1512
• 全文大小：4372 K

文摘

In the trabecular meshwork (TM) of the eye, regulation of tissue contractility by the PPRARI sequence within the Heparin II (HepII) domain of fibronectin is believed to control the movement of aqueous humor and dictate the level of intraocular pressure. This study shows that the HepII domain utilizes activated α4β1 integrin and collagen to mediate a co-signaling pathway that down-regulates contractility in TM cells. siRNA silencing of α4β1 integrin blocked the actin disrupting effects of both PPRARI and the HepII domain. The down-regulation of the actin cytoskeleton and contractility did not involve syndecan-4 or other heparan sulfate proteoglycans (HSPGs) since siRNA silencing of syndecan-4 expression or heparitinase removal of cell surface HSPGs did not prevent the HepII-mediated disruption of the actin cytoskeleton. HepII-mediated disruption of the cytoskeleton depended upon the presence of collagen in the extracellular matrix, and cell binding studies indicated that HepII signaling involved cross-talk between α4β1 and α1/α2β1 integrins. This is the first time that the PPRARI sequence in the HepII domain has been shown to serve as a physiological α4β1 ligand, suggesting that α4β1 integrin may be a key regulator of tissue contractility.